Program for Saturday May 10, 2025

Sponsored by the Teachers Section and Education Committee

Moderator: Lisa Strano-Paul, MD

This program is a faculty development module designed for Undergraduate Medial Education (UME) and Graduate Medical Education (GME) educators. It will review the current state of geriatrics education in UME and GME focusing on Liaison Committee on Medical Education (LCME) and Accreditation Council for Graduate Medical Education (ACGME) accreditation standards. Learning Objectives: (1) describe the current accreditation standards of geriatric education in UME and GME; (2) compare the LCME/ACGME accreditation standards for UME/GME with ADGAP minimal competencies for Geriatric Education; (3) evaluate sample models of successful geriatric curricular enhancements in UME and GME; (4) create and plan models of geriatric education for implementation at home institution.

Sponsored by the Surgical-Geriatric Co-Management SIG and the International Geriatric Fracture Society (IGFS)

Moderator: Kathleen Breda, MSN, BBA, APN, AGACNP-BC, GRN, ONP-C

This symposium focuses on the standards of longitudinal care of hip fracture, from the immediate post-operative time, through post-acute rehab and potential return to their preinjury living environment ensuring seamless transitions throughout an episode of care. Learning Objectives: (1) prevent, identify and treat in-hospital post-operative complications including management of hip fractures including swallowing difficulties, delirium, pain management, DVT prophylaxis and fluid management; (2) define general principles of medical management of post-acute care of hip fracture patients in a skilled nursing facility including medical complications; (3) identify key challenges to physical and occupational rehabilitation in post-acute care settings with the aim of optimizing short term functional recovery; (4) review standards of post-rehab care in the community or LTC, the burden of comorbid conditions, long-term prognosis of hip fracture patients, and the importance of evaluation and treatment of osteoporosis.

Sponsored by the Dementia Care and Caregiver Support SIG, Home-Based Primary Care SIG, and Society of General Internal Medicine-AGS SIG

Co-Moderators: Rachel B. R. Chalmer, MD & Maria F. D’Souza, MD, MPH

The session will begin with an introduction and overview of the topic of non-pharmacologic management of distress symptoms in persons living with dementia (PLWD), also known as behavioral and psychological symptoms of dementia, or BPSD. A brief description will be presented of two leading evidence-based frameworks for non-pharmacologic management of distress symptoms, the DICE (describe, investigate, create, and evaluate) approach and TAP (Tailored Activity Program). A clinical vignette will then be presented for participants to use as the basis for discussion in breakout groups. Learning Objectives: (1) describe the context, etiology and significance of distress symptoms in PLWD; evidence-based frameworks for appropriately utilizing pharmacologic and non-pharmacologic treatment strategies; and available resources to assist clinicians in applying non-pharmacologic strategies for distress symptoms in PLWD; (2) apply evidence-based, problem-solving frameworks to a clinical vignette and learn practical, concrete communications skills to bring back to their practices; (3) explain the role of interprofessional teams in the management of distress symptoms in PLWD; (4) create an action plan for mobilizing existing expertise and resources in their current practices and/or teaching roles.

Sponsored by the Pharmacists Section

Moderator: Tasha Woodall, PharmD, BCGP, CPP

The purpose of this symposium is to educate the audience and summarize the changes over the past year in pharmacotherapy. In addition, the symposium will cover clinical implications of cannabis use in older adults, covering a review of evidence and patient-specific considerations. Learning Objectives: (1) communicate the indication for use, mechanism of action, pharmacokinetics, dosing, safety, and drug interactions for newly approved medications; (2) compare potential advantages and disadvantages of incorporating new medications into clinical practice; (3) explain the clinical implications of cannabis use in older adults; (4) implement best practices for initiating cannabis therapy, including patient education, dosing strategies, and follow-up care.